Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (31-40 of 418) with videos related to

Pageof 42
Sort By:
Clinics in Dermatology|July 22, 2008
Cutaneous manifestations of cardiovascular diseasesAnnemarie Uliasz, Mark Lebwohl
Journal of the American Academy of Dermatology|February 5, 2011
Clinical features of pyoderma gangrenosum and current diagnostic trendsAhmed Hadi, Mark Lebwohl
International Journal of Dermatology|July 24, 2004
Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trialMark Lebwohl, Todd Plott
Medgenmed : Medscape General Medicine|April 7, 2007
A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitisMark Lebwohl, Tara Gower
Journal of the American Academy of Dermatology|January 25, 2025
A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumabMilaan Shah, , Mark Lebwohl
International Journal of Dermatology|May 15, 2010
Evaluation of sensory irritation caused by topical medications using a novel techniqueAnnemarie Uliasz, Mark Lebwohl
Journal of Clinical Medicine|July 2, 2021
Comprehensive Literature Review of Obstetric Outcomes and Fetal Risk during Pregnancy with Pseudoxanthoma ElasticumRaphael Lee, Mark Lebwohl
Dermatologic Clinics|May 25, 2024
Psoriasis Comorbidities and Their Treatment ImpactMark Taliercio, Mark Lebwohl
International Journal of Dermatology|June 29, 2023
Bexarotene use in refractory Darier's diseaseSophie Guenin, Mark Lebwohl
Expert Opinion on Drug Metabolism & Toxicology|February 19, 2010
Alefacept: where it stands todayJinan Chaarani, Mark Lebwohl
Pageof 42

Showing results (31-40 of 418) with videos related to

Sort By:
Pageof 42
Clinics in Dermatology|July 22, 2008
Cutaneous manifestations of cardiovascular diseasesAnnemarie Uliasz, Mark Lebwohl
Journal of the American Academy of Dermatology|February 5, 2011
Clinical features of pyoderma gangrenosum and current diagnostic trendsAhmed Hadi, Mark Lebwohl
International Journal of Dermatology|July 24, 2004
Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trialMark Lebwohl, Todd Plott
Medgenmed : Medscape General Medicine|April 7, 2007
A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitisMark Lebwohl, Tara Gower
Journal of the American Academy of Dermatology|January 25, 2025
A call to action regarding the Risk Evaluation and Mitigation Strategy program for brodalumabMilaan Shah, , Mark Lebwohl
International Journal of Dermatology|May 15, 2010
Evaluation of sensory irritation caused by topical medications using a novel techniqueAnnemarie Uliasz, Mark Lebwohl
Journal of Clinical Medicine|July 2, 2021
Comprehensive Literature Review of Obstetric Outcomes and Fetal Risk during Pregnancy with Pseudoxanthoma ElasticumRaphael Lee, Mark Lebwohl
Dermatologic Clinics|May 25, 2024
Psoriasis Comorbidities and Their Treatment ImpactMark Taliercio, Mark Lebwohl
International Journal of Dermatology|June 29, 2023
Bexarotene use in refractory Darier's diseaseSophie Guenin, Mark Lebwohl
Expert Opinion on Drug Metabolism & Toxicology|February 19, 2010
Alefacept: where it stands todayJinan Chaarani, Mark Lebwohl
Pageof 42